Novel inhibitors of human IDO1 and TDO

被引：1
|
作者：
Banerjee, Monali
Middya, Sandip
Shrivastava, Ritesh
Raina, Sushil
Yadav, Dharmendra
Singh, Satveer
Manna, Anindita
Chakraborty, Debjani
Surya, Arjun
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2015年 / 3卷 / 10期
关键词：
D O I：
10.1158/2326-6074.TUMIMM14-A59
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A59
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Discovery of novel isothiourea derivatives as potent dual inhibitors of IDO1 and TDO
    Ogo, Naohisa
    Muraoka, Daisuke
    Ando, Takayuki
    Asai, Akira
    CANCER SCIENCE, 2021, 112 : 557 - 557
  • [2] In silico discovery and therapeutic potential of IDO1 and TDO2 inhibitors
    Jernigan, Finith E.
    Sun, Lijun
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (12) : 1309 - 1311
  • [3] ROCHE AND CURADEV SIGN IDO1/TDO PACT
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (17) : 15 - 15
  • [4] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [6] Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors
    Platten, Michael
    Doeberitz, Nikolaus von Knebel
    Oezen, Iris
    Wick, Wolfgang
    Ochs, Katharina
    FRONTIERS IN IMMUNOLOGY, 2015, 5
  • [7] 4,6-Substituted-1 H-Indazoles as potent IDO1/TDO dual inhibitors
    Yang, Lingling
    Chen, Yang
    He, Junlin
    Njoya, Emmanuel Mfotie
    Chen, Jianjun
    Liu, Siyan
    Xie, Congqiang
    Huang, Wenze
    Wang, Fei
    Wang, Zhouyu
    Li, Yuzhi
    Qian, Shan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (06) : 1087 - 1098
  • [8] Developing reliable classification of dual IDO1/TDO inhibitors using data fusion and majority voting
    Ghaemi, Zahra
    Asadollahi-Baboli, M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (24): : 13716 - 13724
  • [9] On the non-redundant roles of TDO2 and IDO1
    Puccetti, Paolo
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [10] IDO1 INHIBITORS FOR CANCER IMMUNOTHERAPY
    Alford, B.
    Cox, K.
    Soliman, H.
    DRUGS OF THE FUTURE, 2016, 41 (09) : 553 - 559
12345